Similar Papers

Paper Title
Journal
Date
Author
Data from Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP)
Paolo G Casali ... Annalisa Astolfi
-
Paolo G Casali, et. al.Paolo G Casali ... Annalisa Astolfi
31 Mar 2023
Data from Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP)
Alessandro Gronchi ... Valentina Indio
-
Alessandro Gronchi, et. al.Alessandro Gronchi ... Valentina Indio
31 Mar 2023
Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP).
Silvia Stacchiotti ... Marcella Tazzari
Clinical Cancer Research | VOL. 22
Silvia Stacchiotti, et. al.Silvia Stacchiotti ... Marcella Tazzari
10 Aug 2015
Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans.
Brian P Rubin ... Sohail Mirza
Journal of Clinical Oncology | VOL. 20
Brian P Rubin, et. al.Brian P Rubin ... Sohail Mirza
01 Sep 2002
View more papers

More From: The Journal of Dermatology

Paper Title
Journal
Date
Author
Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment.
Brett Hauber ... Robert Wolk
The Journal of dermatology | VOL. -
Brett Hauber, et. al.Brett Hauber ... Robert Wolk
15 Jan 2025
Exploring itch in hidradenitis suppurativa with lessons from atopic dermatitis and psoriasis.
Nicole Trupiano ... Iltefat Hamzavi
The Journal of dermatology | VOL. -
Nicole Trupiano, et. al.Nicole Trupiano ... Iltefat Hamzavi
15 Jan 2025
Treatment of facial reactive B-cell rich lymphoid proliferation with dapsone.
Makoto Sugaya ... Masaru Tanaka
The Journal of dermatology | VOL. -
Makoto Sugaya, et. al.Makoto Sugaya ... Masaru Tanaka
13 Jan 2025
A case of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia diagnosed with facial lesions.
Kozo Kawaguchi ... Takeshi Nakahara
The Journal of dermatology | VOL. -
Kozo Kawaguchi, et. al.Kozo Kawaguchi ... Takeshi Nakahara
11 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.